BPC-157 Laboratory Research BPC-157 is a synthetic pentadecapeptide that has been investigated in laboratory research involving peptide biology, receptor interactions, molecular signaling pathways, protein expression, cellular communication, and experimental pharmacology
Considering the latter possibility, treatments that were considered failures in previous clinical trials could be reanalyzed for potential efficacy in ALS, taking into account the duration of the disease at the start of therapy. Therefore, using diagnostic criteria that enables earlier identification of the disease and a change in the physicians attitude towards offering an early diagnosis and treatment could result in better ALS patient outcomes.
Decorin goes up 302%
Harty PS, Zabriskie HA, Erickson JL, Molling PE, Kerksick CM, Jagim AR
8-12 week cycle is optimal
This remains speculative and requires direct clinical data to confirm